Senzo is a deep-tech bio-med company developing testing products and IP.
Senzo has raised $1.8M in total funding. The most recent round was Undisclosed. The last funding was announced in October 2023.
Senzo's investors include BioAdvance, Bossa Invest, SOSV, SOSV SF & NY (Fka IndieBio), Wellness Coaches USA.
Senzo is headquartered in San Francisco, United States.
Senzo is a deep-tech bio-med company developing testing products and IP.
Senzo is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Senzo — Funding & Investors." VCBacked, October 4, 2023, https://www.vcbacked.co/company/senzo. Accessed August 13, 2026.
VCBacked. (2023). Senzo — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/senzo
{{cite web |title=Senzo — Funding & Investors |url=https://www.vcbacked.co/company/senzo |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated